English
简体中文
Total: £ 56.28
Published Date: 2025-11-07 | Pages: 122 | Tables: 120 | Medical Care
The global Bioinformatics Sequencing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Bioinformatics Sequencing Service leading manufacturers including Illumina, GENEWIZ, CD Genomics, PacBio, Roche, Macrogen, BGI, Novo Gene, Berry Genomics, Qiagen N.V., etc., dominate supply; the top five capture approximately % of global revenue, with Illumina leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bioinformatics Sequencing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Illumina
GENEWIZ
CD Genomics
PacBio
Roche
Macrogen
BGI
Novo Gene
Berry Genomics
Qiagen N.V.
Segment by Type
DNA Sequencing Service
RNA Sequencing Service
Segment by Application
Research
Clinical
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Bioinformatics Sequencing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Bioinformatics Sequencing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bioinformatics Sequencing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DNA Sequencing Service
1.2.3 RNA Sequencing Service
1.3 Market Segmentation by Application
1.3.1 Global Bioinformatics Sequencing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Research
1.3.3 Clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bioinformatics Sequencing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Bioinformatics Sequencing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Bioinformatics Sequencing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Bioinformatics Sequencing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 DNA Sequencing Service Market Size by Players
3.3.2 RNA Sequencing Service Market Size by Players
3.4 Global Bioinformatics Sequencing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bioinformatics Sequencing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bioinformatics Sequencing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Bioinformatics Sequencing Service Market Size by Type (2020-2031)
6.4 North America Bioinformatics Sequencing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bioinformatics Sequencing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Bioinformatics Sequencing Service Market Size by Type (2020-2031)
7.4 Europe Bioinformatics Sequencing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bioinformatics Sequencing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Bioinformatics Sequencing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Bioinformatics Sequencing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Bioinformatics Sequencing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Bioinformatics Sequencing Service Market Size by Type (2020-2031)
9.4 Central and South America Bioinformatics Sequencing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bioinformatics Sequencing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Bioinformatics Sequencing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Bioinformatics Sequencing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bioinformatics Sequencing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina Bioinformatics Sequencing Service Product Features and Attributes
11.1.4 Illumina Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.1.5 Illumina Bioinformatics Sequencing Service Revenue by Product in 2024
11.1.6 Illumina Bioinformatics Sequencing Service Revenue by Application in 2024
11.1.7 Illumina Bioinformatics Sequencing Service Revenue by Geographic Area in 2024
11.1.8 Illumina Bioinformatics Sequencing Service SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 GENEWIZ
11.2.1 GENEWIZ Corporation Information
11.2.2 GENEWIZ Business Overview
11.2.3 GENEWIZ Bioinformatics Sequencing Service Product Features and Attributes
11.2.4 GENEWIZ Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.2.5 GENEWIZ Bioinformatics Sequencing Service Revenue by Product in 2024
11.2.6 GENEWIZ Bioinformatics Sequencing Service Revenue by Application in 2024
11.2.7 GENEWIZ Bioinformatics Sequencing Service Revenue by Geographic Area in 2024
11.2.8 GENEWIZ Bioinformatics Sequencing Service SWOT Analysis
11.2.9 GENEWIZ Recent Developments
11.3 CD Genomics
11.3.1 CD Genomics Corporation Information
11.3.2 CD Genomics Business Overview
11.3.3 CD Genomics Bioinformatics Sequencing Service Product Features and Attributes
11.3.4 CD Genomics Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.3.5 CD Genomics Bioinformatics Sequencing Service Revenue by Product in 2024
11.3.6 CD Genomics Bioinformatics Sequencing Service Revenue by Application in 2024
11.3.7 CD Genomics Bioinformatics Sequencing Service Revenue by Geographic Area in 2024
11.3.8 CD Genomics Bioinformatics Sequencing Service SWOT Analysis
11.3.9 CD Genomics Recent Developments
11.4 PacBio
11.4.1 PacBio Corporation Information
11.4.2 PacBio Business Overview
11.4.3 PacBio Bioinformatics Sequencing Service Product Features and Attributes
11.4.4 PacBio Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.4.5 PacBio Bioinformatics Sequencing Service Revenue by Product in 2024
11.4.6 PacBio Bioinformatics Sequencing Service Revenue by Application in 2024
11.4.7 PacBio Bioinformatics Sequencing Service Revenue by Geographic Area in 2024
11.4.8 PacBio Bioinformatics Sequencing Service SWOT Analysis
11.4.9 PacBio Recent Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Business Overview
11.5.3 Roche Bioinformatics Sequencing Service Product Features and Attributes
11.5.4 Roche Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.5.5 Roche Bioinformatics Sequencing Service Revenue by Product in 2024
11.5.6 Roche Bioinformatics Sequencing Service Revenue by Application in 2024
11.5.7 Roche Bioinformatics Sequencing Service Revenue by Geographic Area in 2024
11.5.8 Roche Bioinformatics Sequencing Service SWOT Analysis
11.5.9 Roche Recent Developments
11.6 Macrogen
11.6.1 Macrogen Corporation Information
11.6.2 Macrogen Business Overview
11.6.3 Macrogen Bioinformatics Sequencing Service Product Features and Attributes
11.6.4 Macrogen Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.6.5 Macrogen Recent Developments
11.7 BGI
11.7.1 BGI Corporation Information
11.7.2 BGI Business Overview
11.7.3 BGI Bioinformatics Sequencing Service Product Features and Attributes
11.7.4 BGI Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.7.5 BGI Recent Developments
11.8 Novo Gene
11.8.1 Novo Gene Corporation Information
11.8.2 Novo Gene Business Overview
11.8.3 Novo Gene Bioinformatics Sequencing Service Product Features and Attributes
11.8.4 Novo Gene Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.8.5 Novo Gene Recent Developments
11.9 Berry Genomics
11.9.1 Berry Genomics Corporation Information
11.9.2 Berry Genomics Business Overview
11.9.3 Berry Genomics Bioinformatics Sequencing Service Product Features and Attributes
11.9.4 Berry Genomics Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.9.5 Berry Genomics Recent Developments
11.10 Qiagen N.V.
11.10.1 Qiagen N.V. Corporation Information
11.10.2 Qiagen N.V. Business Overview
11.10.3 Qiagen N.V. Bioinformatics Sequencing Service Product Features and Attributes
11.10.4 Qiagen N.V. Bioinformatics Sequencing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Bioinformatics Sequencing ServiceIndustry Chain Analysis
12.1 Bioinformatics Sequencing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bioinformatics Sequencing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bioinformatics Sequencing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Bioinformatics Sequencing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bioinformatics Sequencing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bioinformatics Sequencing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bioinformatics Sequencing Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bioinformatics Sequencing Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Bioinformatics Sequencing Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Bioinformatics Sequencing Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Bioinformatics Sequencing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioinformatics Sequencing Service as of 2024)
Table 11. Global Bioinformatics Sequencing Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Bioinformatics Sequencing Service Companies Headquarters
Table 13. Global Bioinformatics Sequencing Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Bioinformatics Sequencing Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Bioinformatics Sequencing Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Bioinformatics Sequencing Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Bioinformatics Sequencing Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Bioinformatics Sequencing Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Bioinformatics Sequencing Service Growth Accelerators and Market Barriers
Table 25. North America Bioinformatics Sequencing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Bioinformatics Sequencing Service Growth Accelerators and Market Barriers
Table 27. Europe Bioinformatics Sequencing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Bioinformatics Sequencing Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Bioinformatics Sequencing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Bioinformatics Sequencing Service Investment Opportunities and Key Challenges
Table 31. Central and South America Bioinformatics Sequencing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Bioinformatics Sequencing Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Bioinformatics Sequencing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina Bioinformatics Sequencing Service SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. GENEWIZ Corporation Information
Table 44. GENEWIZ Description and Major Businesses
Table 45. GENEWIZ Product Features and Attributes
Table 46. GENEWIZ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. GENEWIZ Revenue Proportion by Product in 2024
Table 48. GENEWIZ Revenue Proportion by Application in 2024
Table 49. GENEWIZ Revenue Proportion by Geographic Area in 2024
Table 50. GENEWIZ Bioinformatics Sequencing Service SWOT Analysis
Table 51. GENEWIZ Recent Developments
Table 52. CD Genomics Corporation Information
Table 53. CD Genomics Description and Major Businesses
Table 54. CD Genomics Product Features and Attributes
Table 55. CD Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. CD Genomics Revenue Proportion by Product in 2024
Table 57. CD Genomics Revenue Proportion by Application in 2024
Table 58. CD Genomics Revenue Proportion by Geographic Area in 2024
Table 59. CD Genomics Bioinformatics Sequencing Service SWOT Analysis
Table 60. CD Genomics Recent Developments
Table 61. PacBio Corporation Information
Table 62. PacBio Description and Major Businesses
Table 63. PacBio Product Features and Attributes
Table 64. PacBio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. PacBio Revenue Proportion by Product in 2024
Table 66. PacBio Revenue Proportion by Application in 2024
Table 67. PacBio Revenue Proportion by Geographic Area in 2024
Table 68. PacBio Bioinformatics Sequencing Service SWOT Analysis
Table 69. PacBio Recent Developments
Table 70. Roche Corporation Information
Table 71. Roche Description and Major Businesses
Table 72. Roche Product Features and Attributes
Table 73. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Roche Revenue Proportion by Product in 2024
Table 75. Roche Revenue Proportion by Application in 2024
Table 76. Roche Revenue Proportion by Geographic Area in 2024
Table 77. Roche Bioinformatics Sequencing Service SWOT Analysis
Table 78. Roche Recent Developments
Table 79. Macrogen Corporation Information
Table 80. Macrogen Description and Major Businesses
Table 81. Macrogen Product Features and Attributes
Table 82. Macrogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Macrogen Recent Developments
Table 84. BGI Corporation Information
Table 85. BGI Description and Major Businesses
Table 86. BGI Product Features and Attributes
Table 87. BGI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. BGI Recent Developments
Table 89. Novo Gene Corporation Information
Table 90. Novo Gene Description and Major Businesses
Table 91. Novo Gene Product Features and Attributes
Table 92. Novo Gene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Novo Gene Recent Developments
Table 94. Berry Genomics Corporation Information
Table 95. Berry Genomics Description and Major Businesses
Table 96. Berry Genomics Product Features and Attributes
Table 97. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Berry Genomics Recent Developments
Table 99. Qiagen N.V. Corporation Information
Table 100. Qiagen N.V. Description and Major Businesses
Table 101. Qiagen N.V. Product Features and Attributes
Table 102. Qiagen N.V. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Qiagen N.V. Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Bioinformatics Sequencing Service Product Picture
Figure 2. Global Bioinformatics Sequencing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. DNA Sequencing Service Product Picture
Figure 4. RNA Sequencing Service Product Picture
Figure 5. Global Bioinformatics Sequencing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Research
Figure 7. Clinical
Figure 8. Bioinformatics Sequencing Service Report Years Considered
Figure 9. Global Bioinformatics Sequencing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 11. Global Bioinformatics Sequencing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Bioinformatics Sequencing Service Revenue Market Share by Region (2020-2031)
Figure 13. Global Bioinformatics Sequencing Service Revenue Market Share Ranking (2024)
Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 15. DNA Sequencing Service Revenue Market Share by Player in 2024
Figure 16. RNA Sequencing Service Revenue Market Share by Player in 2024
Figure 17. Global Bioinformatics Sequencing Service Revenue Market Share by Type (2020-2031)
Figure 18. Global Bioinformatics Sequencing Service Revenue Market Share by Application (2020-2031)
Figure 19. North America Bioinformatics Sequencing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 20. North America Top 5 Players Bioinformatics Sequencing Service Revenue (US$ Million) in 2024
Figure 21. North America Bioinformatics Sequencing Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 22. North America Bioinformatics Sequencing Service Revenue (US$ Million) by Application (2020-2031)
Figure 23. US Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 24. Canada Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 25. Mexico Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 26. Europe Bioinformatics Sequencing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 27. Europe Top 5 Players Bioinformatics Sequencing Service Revenue (US$ Million) in 2024
Figure 28. Europe Bioinformatics Sequencing Service Revenue (US$ Million) by Type (2020-2031)
Figure 29. Europe Bioinformatics Sequencing Service Revenue (US$ Million) by Application (2020-2031)
Figure 30. Germany Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 31. France Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 32. U.K. Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 33. Italy Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 34. Russia Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Bioinformatics Sequencing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Top 8 Players Bioinformatics Sequencing Service Revenue (US$ Million) in 2024
Figure 37. Asia-Pacific Bioinformatics Sequencing Service Revenue (US$ Million) by Type (2020-2031)
Figure 38. Asia-Pacific Bioinformatics Sequencing Service Revenue (US$ Million) by Application (2020-2031)
Figure 39. Indonesia Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 40. Japan Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 41. South Korea Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 42. Australia Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 43. India Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 44. Indonesia Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 45. Vietnam Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 46. Malaysia Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 47. Philippines Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 48. Singapore Bioinformatics Sequencing Service Revenue (2020-2031) & (US$ Million)
Figure 49. Central and South America Bioinformatics Sequencing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Central and South America Top 5 Players Bioinformatics Sequencing Service Revenue (US$ Million) in 2024
Figure 51. Central and South America Bioinformatics Sequencing Service Revenue (US$ Million) by Type (2020-2031)
Figure 52. Central and South America Bioinformatics Sequencing Service Revenue (US$ Million) by Application (2020-2031)
Figure 53. Brazil Bioinformatics Sequencing Service Revenue (2020-2025) & (US$ Million)
Figure 54. Argentina Bioinformatics Sequencing Service Revenue (2020-2025) & (US$ Million)
Figure 55. Middle East and Africa Bioinformatics Sequencing Service Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Middle East and Africa Top 5 Players Bioinformatics Sequencing Service Revenue (US$ Million) in 2024
Figure 57. South America Bioinformatics Sequencing Service Revenue (US$ Million) by Type (2020-2031)
Figure 58. Middle East and Africa Bioinformatics Sequencing Service Revenue (US$ Million) by Application (2020-2031)
Figure 59. GCC Countries Bioinformatics Sequencing Service Revenue (2020-2025) & (US$ Million)
Figure 60. Israel Bioinformatics Sequencing Service Revenue (2020-2025) & (US$ Million)
Figure 61. Egypt Bioinformatics Sequencing Service Revenue (2020-2025) & (US$ Million)
Figure 62. South Africa Bioinformatics Sequencing Service Revenue (2020-2025) & (US$ Million)
Figure 63. Bioinformatics Sequencing Service Industry Chain Mapping
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
